SignalXSignalX

INVA Innoviva, Inc.

8-K Current Report
Filed: February 25, 2026
Health Care
Pharmaceutical Preparations
Innoviva, Inc. Overview

Innoviva, Inc. (INVA) 8-K current report filed with SEC EDGAR on February 25, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

  • Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

  • • Q results press release attached as Exhibit 99.1 — refer to exhibit for all financial figures and key metrics
  • • Filing furnished (not filed) under SEC rules — limits legal liability, standard practice for earnings releases

Get deeper insights on Innoviva, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.